J
Johnson & Johnson (JNJ)
NYQ – Real vaqt narxi. Valyuta: USD
224.26
+2.83 (1.28%)
Yopilishda: May 12, 2026, 4:00 PM EDT
224.37
+0.11 (0.05%)
Bozordan keyin: May 12, 2026, 7:59 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NYQ – Real vaqt narxi. Valyuta: USD
224.26
+2.83 (1.28%)
Yopilishda: May 12, 2026, 4:00 PM EDT
224.37
+0.11 (0.05%)
Bozordan keyin: May 12, 2026, 7:59 PM EDT
Johnson & Johnson, sho'ba korxonalari bilan birgalikda, dunyo bo'ylab sog'liqni saqlash sohasidagi bir qator mahsulotlarni tadqiq qilish va ishlab chiqish, ishlab chiqarish va sotish bilan shug'ullanadi. U ikkita segmentda faoliyat yuritadi: Innovative Medicine (Innovatsion tibbiyot) va MedTech (Medtexnologiya). Innovative Medicine segmenti onkologiya, immunologiya, nevrologiya, o'pka gipertenziyasi, yuqumli kasalliklar, shuningdek, yurak-qon tomir va metabolizm kabi turli terapevtik sohalar uchun mahsulotlarni taklif qiladi, ular chakana savdogarlar, ulgurji sotuvchilar, distribyutorlar, shifoxonalar va sog'liqni saqlash mutaxassislari orqali retsept bo'yicha foydalanish uchun tarqatiladi. MedTech segmenti jarrohlik, ortopediya, yurak-qon tomir va ko'z sohalarida ishlatiladigan mahsulotlar portfelini taqdim etadi, ular ulgurji sotuvchilar, shifoxonalar va chakana savdogarlar orqali tarqatiladi va shifokorlar, hamshiralar, shifoxonalar, ko'z kasalliklari mutaxassislari va klinikalari tomonidan professional sohalarda ishlatiladi. Ushbu segment, shuningdek, bo'g'im rekonstruktsiyasi, travma, umurtqa pog'onasi, sport bilan bog'liq jarohatlar va boshqa muolajalarni, shuningdek, ochiq, laparoskopik va robotli jarrohlik muolajalarini qo'llab-quvvatlovchi mahsulotlar va texnologiyalarni taklif etadi; asboblar, energiya qurilmalari, tikuv tizimlari, yaralarni yopish vositalari, biosurgery mahsulotlari, shuningdek, raqamli va robot texnologiyalari; ko'krak estetikasi va rekonstruktsiyasi; ACUVUE brendi ostidagi kontakt linzalari; katarakta jarrohligi uchun intraokulyar linzalar va TECNIS brendi ostidagi katarakta va refraktiv muolajalar uchun ishlatiladigan boshqa mahsulotlar. Kompaniya 1886 yilda tashkil etilgan va Nyu-Brunsvik, Nyu-Jersi shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Dr. John C. Reed M.D., Ph.D. | Executive Vice President of Innovative Medicine and R&D |
| Mr. Dirk Brinckman | Chief Compliance Officer |
| Mr. James Swanson | Executive VP & Chief Information Officer |
| Mr. Joaquin Duato | CEO & Chairman |
| Mr. Joseph James Wolk CPA | Executive VP & CFO |
| Mr. Robert J. Decker Jr. | Controller & Chief Accounting Officer |
| Mr. Timothy Schmid | Executive VP & Worldwide Chairman of MedTech |
| Ms. Elizabeth Forminard J.D. | Executive VP & Chief Legal Officer |
| Ms. Jennifer L. Taubert | Executive VP & Worldwide Chairman of Innovative Medicine |
| Ms. Kristen Blair Mulholland | Executive VP & Chief Human Resources Officer |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-28 | 8-K | jnj-20260423.htm |
| 2026-04-22 | 10-Q | jnj-20260329.htm |
| 2026-04-14 | 8-K | jnj-20260414.htm |
| 2026-03-11 | DEFA14A | a2026jnjdefa14a-additional.htm |
| 2026-03-11 | ARS | jnj014992-ars.pdf |
| 2026-02-11 | S-3ASR | d80821ds3asr.htm |
| 2026-01-21 | 8-K | jnj-20260121.htm |
| 2025-10-22 | 10-Q | jnj-20250928.htm |
| 2025-10-14 | 8-K | jnj-20251014.htm |
| 2025-09-09 | 8-K | jnj-20250908.htm |